Atomi Financial Group Inc. Cuts Stock Holdings in CVS Health Co. (NYSE:CVS)

Atomi Financial Group Inc. lowered its stake in shares of CVS Health Co. (NYSE:CVS) by 28.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 14,529 shares of the pharmacy operator’s stock after selling 5,855 shares during the period. Atomi Financial Group Inc.’s holdings in CVS Health were worth $652,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Ballentine Partners LLC raised its stake in shares of CVS Health by 17.5% in the 4th quarter. Ballentine Partners LLC now owns 5,314 shares of the pharmacy operator’s stock valued at $239,000 after acquiring an additional 793 shares during the period. LaFleur & Godfrey LLC raised its stake in shares of CVS Health by 49.9% in the 4th quarter. LaFleur & Godfrey LLC now owns 4,836 shares of the pharmacy operator’s stock valued at $217,000 after acquiring an additional 1,610 shares during the period. AHL Investment Management Inc. raised its stake in shares of CVS Health by 1.7% in the 4th quarter. AHL Investment Management Inc. now owns 43,316 shares of the pharmacy operator’s stock valued at $1,944,000 after acquiring an additional 713 shares during the period. M.E. Allison & CO. Inc. purchased a new position in shares of CVS Health in the 4th quarter valued at $277,000. Finally, Diversify Wealth Management LLC raised its stake in shares of CVS Health by 2.6% in the 4th quarter. Diversify Wealth Management LLC now owns 16,181 shares of the pharmacy operator’s stock valued at $777,000 after acquiring an additional 408 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on CVS shares. Barclays dropped their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. TD Cowen lifted their price target on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. Mizuho dropped their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Piper Sandler dropped their price target on shares of CVS Health from $72.00 to $64.00 and set an “overweight” rating on the stock in a research note on Monday, November 25th. Finally, StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a research note on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $68.71.

CVS Health Trading Up 1.7 %

Shares of NYSE:CVS opened at $53.87 on Friday. The company has a market cap of $67.79 billion, a PE ratio of 13.67, a P/E/G ratio of 0.80 and a beta of 0.59. The company’s 50-day moving average price is $51.23 and its 200 day moving average price is $56.24. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The firm had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same period last year, the firm posted $2.21 EPS. Sell-side analysts anticipate that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date is Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.94%. CVS Health’s dividend payout ratio (DPR) is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.